NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hyasynth Biologicals Inc.

Hyasynth Biologicals Inc.

Private
MontrealHealthcare & Life Scienceshttps://hyasynthbio.com

Last Round

Convertible Debt

Dec 22, 2021

Total Funding Raised

$10.05M

Company Overview

Hyasynth Biologicals Inc. is a biotechnology company that produces pure, sustainable cannabinoid ingredients through precision fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

synthetic biologyyeast fermentationcannabinoid biosynthesislab-grown cannabinoidsfermentation technologycannabidiolCBDcannabigerolCBGmetabolic engineeringprecision fermentationbiological manufacturingbiotech ingredientsstrain developmentclean manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hyasynth Biologicals Inc. Comparables

Compare Hyasynth Biologicals Inc. with similar companies based on industry and business-model similarity.

Hyasynth Biologicals Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomedican
93%
Purissima
87%
Creo
86%

Hyasynth Biologicals Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtDec 22, 2021
Convertible DebtOct 23, 2020
Convertible DebtSep 13, 2018
SeedNov 30, 2017
AcceleratorNov 12, 2014

Key People

Founding team and executive leadership

Zach Wiltshire

Head of People Operations, COO and President, Co-founder, Director, Board of Directors

Founding Team

Hyasynth Biologicals Inc. Investors

Notable investors and investment history

Hyasynth Biologicals Inc. investors
InvestorRounds
IndieBioAccelerator
Anges QuebecSeed
MassChallenge IsraelSeed
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 79% MoM.

  • Dec 22, 2021

    $3M raised from Organigram Global Inc.

Hyasynth Biologicals Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hyasynth Biologicals Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hyasynth Biologicals Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range5
Year Founded2014
Last FundingDec 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.